Bioorganic and Medicinal Chemistry Letters p. 803 - 806 (1996)
Update date:2022-09-26
Topics:
Chapman, Kevin T.
Durette, Philippe L.
Caldwell, Charles G.
Sperow, Kelly M.
Niedzwiecki, Lisa M.
Harrison, Richard K.
Saphos, Cheryl
Christen, Amy J.
Olszewski, Julie M.
Moore, Vernon L.
MacCoss, Malcolm
Hagmann, William K.
Further development of N-carboxyalkyl dipeptide inhibitors of stromelysin-1 (MMP-3) led to the discovery of C-carboxyalkyl dipeptide analogs with improved oral bioavailability. An in vivo assay of human MMP-3 mediated degradation of a macromolecular substrate in an extravascular space is described and inhibition studies are reported.
View MoreLuojiang Chenming Biological Products Co
Contact:+86 15000297032
Address:GROUP NO.4, HE SHENG VILLAGE, PANLONG TOWN,
Contact:+86-571-86025531 / 86024803
Address:1218-24 Guangyin Mansion,42 Fengqi East Road
SHANXI JINJIN CHEMICAL INDUSTRIAL CO.,LTD
website:http://www.jinjingroup.com
Contact:86-574-13989382828
Address:Economic And Technological Development Zone,Hejin?City,Shanxi Province?,China
Wuhan Shangrisyn chemicals Technology Co.,Ltd(expird)
Contact:+86-027-84466317 __ +86-15387123698
Address:wuhan - china
Tianjin Dongchang Fine Chemical Industry Co., Ltd.
Contact:+86-22-29894595
Address:Economic Developing Zone, Ji County, Tianjin, China
Doi:10.1016/0008-6215(67)85008-0
(1967)Doi:10.1021/om990385y
(2000)Doi:10.1002/ejoc.201402180
(2014)Doi:10.1039/C19660000355
(1966)Doi:10.1016/0040-4039(95)00387-R
(1995)Doi:10.1021/jo00099a037
(1994)
